Price movement over the last 24 hours
Agilent Technologies Inc vs Invesco DB Oil Fund — how do they compare? Agilent Technologies Inc trades at $128.07 (market cap $37.04B), while Invesco DB Oil Fund trades at $18.98. The key difference: Agilent Technologies Inc pays a 0.78% dividend while Invesco DB Oil Fund pays none, and Invesco DB Oil Fund is trading nearer its 52-week high, Agilent Technologies Inc nearer its low. Which is the better fit depends on your goals.
| A | DBO | |
|---|---|---|
Market Cap | $37.04B | — |
Sector | Health | Commodities - Energy |
52-Week High | $157.20 | $23.80 |
52-Week Low | $110.24 | $11.98 |
Enterprise Value | $38.59B | — |
Dividend Yield | 0.78% | — |
Signals from Pluang's Aura AI — not financial advice
Agilent Technologies (A) trades at $131.14, up 0.34% on the day, with a bearish technical signal but strong analyst support. The stock shows solid profitability with a net margin of 19.55% and ROE of 21.33%, supported by recent earnings beats. Recent acquisitions like Biocare Medical highlight growth initiatives, while cash flow trends remain positive. Valuation ratios such as P/E of 26.22 are elevated but align with quality growth expectations.
The outlook is positive given analyst consensus with a $154.90 price target and 77.5% buy ratings. Risks include execution of acquisitions and macroeconomic pressures on life sciences spending. The stock offers growth potential from AI-driven product launches, though technical resistance near $132 may cap near-term gains.
DBO trades at $17.34 with a modest 0.35% daily gain amid bearish technical signals. The stock shows mixed momentum with oversold RSI readings but faces strong resistance at $18. Recent oil price volatility driven by Middle East tensions and supply disruptions creates both opportunities and risks for energy sector stocks.
The outlook remains cautious with technical indicators favoring bearish momentum, though oversold conditions suggest potential for near-term stabilization. Investment opportunity exists if geopolitical tensions sustain higher oil prices, but risks include supply growth and demand uncertainty that could pressure energy stocks further.
Trailing returns across standard periods
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.
Read more on A →DBO provides exposure to WTI crude oil prices through futures contracts. It is designed for investors seeking a way to invest in the performance of the fossil fuel market without purchasing physical oil barrels.
Read more on DBO →